Liposomal amphotericin B reduces duration of L. tropica in children

  • July 30, 2014

Systemic therapy with liposomal amphotericin B resulted in a considerably shorter duration of Leishmania tropica in children than treatment with pentavalent antimony, according to study findings.

In the retrospective study, 47 children with L. tropica cutaneous leishmaniasis were treated with topical or systemic therapy with liposomal amphotericin B (L-AmB) or pentavalent antimony.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Financial Planning
  • Advice for physicians
  • Be aware of important 2014 IRA updates. Analysis by Certified Financial Planner Ken Rudzinski.
More »